Immune Design Corp. Restructuring and Related Cost, Expected Cost Remaining
Immune Design Corp. had Restructuring and Related Cost, Expected Cost Remaining of $100.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Notes
us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1 · last filed 2019-03-13
- 2018-12-31: Restructuring and Related Cost, Expected Cost Remaining $100.00K.
| Period end | Restructuring and Related Cost, Expected Cost Remaining |
|---|---|
| 2018-12-31 | $100.00K 10-K · filed 2019-03-13 |